Please sign in to follow a disease.
Massive study reveals hidden cost of RSV in kids
NCT ID NCT07264478
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines medical records of 1,100 children under 18 from hospitals across China who were hospitalized with RSV-positive bronchiolitis or pneumonia between 2017 and 2021. Researchers aim to understand how the disease is diagnosed and treated, and what it costs families and the healthcare system. The goal is to provide data that can help create better prevention and treatment strategies for children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. A total of 11 hospitals were selected, each with 100 children, a total of 1100 cases
- Ages
-
0 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Hospitalized patients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia Exclusion Criteria: Inpatients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia are excluded from any of the following criteria: 1. Pneumonia occurring 48 hours after hospitalization; 2. Combined with bronchial foreign body; 3. Participants in clinical trials of drugs or medical devices; 4. Not complete personal and family history and other relevant information.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchiolitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Children's Hospital
Beijing, Beijing Municipality, 100045, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- How long does RSV protection last in a Baby's nose?
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Nasal swab could curb unnecessary antibiotics in pneumonia
- AI-Powered patient education: a new way to prepare parents for home care?
- Can a 5-Day pill tame RSV in the most vulnerable?
- AI could outsmart bacteria: a smarter way to choose antibiotics?